The fourth annual report of the South African Renal Registry summarises the 2015 data on renal replacement therapy (RRT) for patients with end-stage renal disease (ESRD) in South Africa. The South African population increased to 54.96 million in 2015, from 54.00 million in 2014. In December 2015, the number of patients with ESRD who were treated with chronic dialysis or transplantation stood at 10 360, a prevalence of 189 per million population (pmp). The prevalence was 167 pmp in 2013 and 178 pmp in 2014. The increasing prevalence observed is due mainly to the increased numbers of patients accessing haemodialysis in the private sector. In the public sector, which serves 84% of the South African population, the prevalence of RRT (71.9 pmp in 2015) remains at levels close to those reported in 1994 so that the disparity in access continues to increase. The disparities between provinces remain, with Limpopo and Mpumalanga the most under-served, as do the disparities between ethnic groups, with Blacks being the most under-served group.
The platform is currently being expanded to accommodate the African Renal Registry and allow data capture by other African countries. Thus far, our colleagues in Ghana, Zambia and Burundi have joined the African Renal Registry and have stated entering data using our platform.
Definitions
EsrD and start date of rrt. ESRD refers to advanced chronic kidney disease (CKD), which is considered to be irreversible and which requires the initiation of renal replacement therapy. The start date is the date of first haemodialysis (HD), the date of the first peritoneal dialysis (PD) flushes or exchanges, or the date of pre-emptive transplantation (where there is no prior dialysis). For patients who are initially thought to have acute kidney injury (AKI) and are dialysed but who do not recover function and are then continued on chronic RRT, the start date is the date of the first dialysis, even though the diagnosis at that time was AKI and not ESRD.
Initial rrt modality. This is the intended first modality and should normally be the modality being used on day 91 of RRT. This means that someone who presents late and who is started on urgent HD but is soon established on PD will have PD recorded as the initial modality. changes in the responsible treating unit. This refers to a change in the dialysis unit, PD follow-up unit/clinic, or transplant follow-up unit/centre/practice. A transfer entry in the registry is required to record this. This should not be done for short-term transfers when the intention is that the patient will return to the "home" unit, e.g. for holiday dialysis, temporary transfer to a unit with isolation facilities, etc.
Primary renal diagnosis.
Responsible nephrologists/ physicians should assist their data capturers to ensure that this critical information is accurate. We are using the set of renal diagnosis codes of the ERA-EDTA [1] and have mapped all previous entries to these codes. If there is uncertainty about the renal diagnosis, as is often the case with patients who present late, then the primary renal diagnosis should be indicated as "chronic kidney disease (cKD) -aetiology uncertain/unknown". In patients who present with ESRD, small kidneys and hypertension there should not be an automatic default to labelling such patients as having "chronic glomerulonephritis" or "hypertensive renal disease". chronic hypertensive nephropathy or malignant hypertensive nephropathy. This should be selected as the primary renal diagnosis if there is no reason to suspect that the hypertension is secondary to pre-existing renal disease. We suggest that the following criteria be met: hypertension known to precede renal dysfunction, left ventricular hypertrophy, proteinuria <2 g/day, and no evidence of other renal diseases [2, 3] .
Lost to follow-up. The SARR assumes that a functioning transplant is maintained unless there is evidence of a "transplant failure" or death. A dialysis modality is assumed to continue for one year from the date of the last registry entry, in the absence of evidence of death; thereafter the patient is considered lost to follow-up. Patients are also considered lost to follow-up one year after a "transplant failure" entry if no further entries are recorded. recovered renal function. These are patients who have been initiated on chronic HD/PD and who no longer require dialysis. The period of dialysis-free recovery must persist for at least 90 days. If the period of recovery is less than 90 days and dialysis is restarted, there should be no END entry and dialysis is considered to have been continuous. If the period of recovery exceeds 90 days and the patient restarts RRT (even within the same year), there should be an END entry for the initial period of RRT and then a new entry recorded for the patient when he/she starts the second period of RRT, i.e., there will be two registry entries for the same patient.
Ethics approval
The SARR operates as a longitudinal study with ethics approval from the Health Research Ethics Committee of Stellenbosch University (reference no. N11/01/028). This is renewed annually upon submission of a progress report. A waiver of individual informed consent has been granted, and the approval includes country-wide data collection on adults and children, public and private sectors, and the tapping of various data sources to improve the accuracy and completeness of data. These include records available through doctors' practices, dialysis and transplant centres, provider companies, and medical aid funds.
rEsULts south Africa in 2015
According to the Stats SA mid-year estimates for 2015 [4] , the population of South Africa increased by nearly one million from the previous year to 54.96 million people. There was a slight female predominance (51.1%). Black/ African citizens constituted 80.5% of the population, with people of mixed ethnicity (Coloured) making up 8.8%, Whites 8.3% and Indians/Asians 2.5%. The province of Gauteng had the largest population, followed by KwaZulu-Natal.
South Africa is classified as an upper-middle income country by the World Bank, with a GNI per capita by the Atlas method (current US$) of $6 090 and by the purchasing 
treatment centres for dialysis and transplantation
An additional 33 treatment centres, 32 of these in the private sector, contributed data for this 2015 report. The total number of centres in 2015 was 258; 228 (88.4%) of these were privately owned. One privately owned unit in Limpopo was established as a public-private partnership on the premises of a government hospital to serve public sector patients.
Prevalence of renal replacement therapy
The total number of patients on RRT on 31 December 2015 was 10 360. With a population of 54.96 million, this is a prevalence of 189 per million population (pmp). The prevalence for 2014 was 178 pmp. In 2015, the province with the highest patient numbers was Gauteng, followed by KwaZulu-Natal and the Western Cape, while the province with the highest prevalence was the Western Cape, followed by Gauteng and KwaZulu-Natal.
SA Renal Registry Annual Report 2015 The number of patients treated in the public sector in 2015 remained low, with a prevalence of 71.9 pmp. This is lower than the rate of 72.6 pmp reported for 2014. In the private sector, the rate increased from 716.3 pmp in 2014 to 799.3 pmp in 2015. Denominators for prevalence calculations are based on the Stats SA mid-term estimates [4] and the Council for Medical Schemes Annual Report [5] .
Medical aid beneficiaries who are unclassified with respect to province were allocated to provinces in proportion to the numbers of beneficiaries in each province.
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Demographic and clinical data
The mean age of the patients on RRT was 51.3 ± 15.0 years and 59.3% were male. Because of the rationing and selection criteria applied in South African public sector hospitals [6] , patients treated there are much younger than those treated in the private sector (43.4 ± 13.5 versus 55.0 ± 14.3 years). Just more than half of the patients were Black. However, the prevalence was still lowest in Blacks (125 pmp) and highest in Indians/Asians (927 pmp). During the 2015 data collection process, we recoded many patients' primary renal diagnoses (PRD) to be in line with the new EDTA-ERA coding system [1] . Taking a conservative approach, we indicated the PRD as "chronic kidney disease/chronic renal failure -aetiology uncertain/ unknown" when it seemed that there was doubt about the diagnosis. For example, because of the links to ICD10 codes in previous versions of the SARR, many patients had a PRD of "chronic renal failure -includes: chronic uraemia, diffuse sclerosing glomerulonephritis" and these had been grouped under glomerular disease. They have now been coded as "uncertain/unknown" and this group is now the largest, followed by hypertensive renal disease and diabetic nephropathy.
Of the 8 002 patients with data on diabetes status, 51.5% were diabetic, with a much higher percentage of diabetic patients in the private than in the public sector (58.0% versus 38.2%). These percentages are substantially higher than those we have reported in the past. One reason for this may be that, for this report, we considered patients as diabetic if any previous entry indicated a patient as being diabetic even when the latest annual assessment had an entry for diabetes status as "unknown". We also classified patients as diabetic when the PRD was given as diabetic nephropathy. In addition, we are concerned that data capturers may have found the options for diabetes on our online form confusing and selected "diabetes (type unknown") instead of "unknown" when they were not sure of the diabetes status.
The seropositive rate for hepatitis B virus was 1.3% (95 of 7 056 patients), for hepatitis C virus 1.1% (65 of 6 178 patients) and for HIV 9.4% (607 of 6 464 patients).
DIscUssION
The number of patients on RRT in South Africa has continued to increase steadily, and stood at 10 360 in December 2015, a prevalence of 189 pmp. In 2014, the prevalence was 178 pmp. As before, this growth was mainly due to an increase in the number of patients treated with haemodialysis in the private healthcare sector. There is no evidence of any real growth in public sector access to RRT and treatment rates over the past few years remain similar to those seen in 1994. The progressive realisation of access to RRT, which is promised by the South African Constitution, is not happening, and this is cause for great concern.
It is vital that a complete picture of renal replacement therapy across the country is obtained and we therefore need the support of all treatment centres to ensure the inclusion of all patients. Our next round of data collection, for December 2016, is currently under way. Treatment centres should re-check their patients' core data, such as demographic information, the date on which treatment was started, the primary renal diagnosis and diabetes status. Any changes in treatment modality, transfers to another centre, and deaths during the year 2016 need to be recorded.
During the course of the next year we will audit and improve the accuracy of our data on primary renal diagnosis and diabetes status, and we will continue to adapt our platform to accommodate countries that have joined the African Renal Registry initiative.
The doctors, nurses, technologists, support staff and management of participating treatment centres -these centres are listed in Appendix 1.
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